Compare Alcon AG (ALC) vs Global E Online Ltd (GLBE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Global E Online Ltd — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Global E Online Ltd trades at $36 (market cap $6.21B). The key difference: Alcon AG is far larger — about 5.3× Global E Online Ltd's market cap, and Alcon AG pays a 0.54% dividend while Global E Online Ltd pays none. Which is the better fit depends on your goals.
| ALC | GLBE | |
|---|---|---|
Market Cap | $32.69B | $6.21B |
Sector | Health | Technology |
52-Week High | $92.22 | $41.59 |
52-Week Low | $62.02 | $27.54 |
Enterprise Value | $36.28B | $5.68B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
GLBE trades at $37.31, up 1.25% today, with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with 33% revenue growth in Q1 2026 and expanding adjusted EBITDA margins to 19.9%. Recent acquisition of Passport enhances logistics capabilities, while a $500 million share repurchase program signals management confidence. Technical indicators show the stock trading near resistance at $38 with RSI levels suggesting potential overbought conditions.
GLBE presents a compelling growth story with accelerating international expansion and strong merchant adoption. However, elevated valuation multiples (P/E of 55.69) and recent insider selling warrant caution. The stock's proximity to analyst price targets suggests limited near-term upside, while execution risks around the Passport integration represent key challenges for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Global E Online Ltd
Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →
